Franklin Resources Inc. Has $8.89 Million Stock Position in DaVita Inc. (NYSE:DVA)

Franklin Resources Inc. raised its holdings in shares of DaVita Inc. (NYSE:DVAFree Report) by 134.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 54,901 shares of the company’s stock after purchasing an additional 31,502 shares during the period. Franklin Resources Inc.’s holdings in DaVita were worth $8,885,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of DVA. Transcendent Capital Group LLC acquired a new position in DaVita in the third quarter valued at approximately $25,000. Blue Trust Inc. raised its position in shares of DaVita by 58.6% during the 2nd quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after acquiring an additional 78 shares during the last quarter. Family Firm Inc. acquired a new position in shares of DaVita in the 2nd quarter valued at $43,000. Quarry LP acquired a new stake in shares of DaVita during the third quarter worth $60,000. Finally, Point72 Hong Kong Ltd bought a new stake in DaVita in the second quarter valued at about $68,000. Institutional investors own 90.12% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on DVA shares. Barclays raised their target price on DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Truist Financial boosted their price objective on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a report on Monday, October 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, DaVita has a consensus rating of “Hold” and an average target price of $161.80.

Check Out Our Latest Stock Report on DVA

DaVita Trading Up 2.9 %

NYSE:DVA opened at $151.85 on Friday. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. The business’s 50-day simple moving average is $157.00 and its 200-day simple moving average is $150.88. DaVita Inc. has a fifty-two week low of $103.40 and a fifty-two week high of $169.51. The stock has a market capitalization of $12.45 billion, a PE ratio of 16.38, a price-to-earnings-growth ratio of 0.86 and a beta of 0.90.

DaVita (NYSE:DVAGet Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the firm posted $2.85 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Sell-side analysts expect that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

DaVita Profile

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Stories

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVAFree Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.